Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Wed, 11.03.2026
Multitude AG
Company Name:
Multitude AG
ISIN:
CH1398992755
Reason for the research:
Update
Recommendation:
BUY
Target price:
EUR 11
Target price on sight of:
12 months
Last rating change:
Analyst:
Julius Neittamo
Strong profitability expected, set to overachieve guidanceMultitude will report its Q4’25 preliminary results tomorrow. Her [ … ]
Tue, 10.03.2026
Cantourage Group SE
Company Name:
Cantourage Group SE
ISIN:
DE000A3DSV01
Reason for the research:
Update
Recommendation:
BUY
Target price:
EUR 10
Target price on sight of:
12 months
Last rating change:
Analyst:
Christian Sandherr
Valuation remains de-coupled from operationsConsolidated FY24 figures finally out - no surprises, sentiment overhang li [ … ]
Fri, 06.03.2026
Global Fashion Group S.A.
Company Name:
Global Fashion Group S.A.
ISIN:
LU2010095458
Reason for the research:
Update
Recommendation:
BUY
Target price:
EUR 1
Target price on sight of:
12 months
Last rating change:
Analyst:
Christian Sandherr
Turnaround ongoing: first positive adj. EBITDA in history
GFG released its FY25 annual report, delivering results [ … ]
Thu, 05.03.2026
Semperit AG Holding
Company Name:
Semperit AG Holding
ISIN:
AT0000785555
Reason for the research:
Update
Recommendation:
BUY
Target price:
EUR 18.5
Target price on sight of:
12 months
Last rating change:
Analyst:
Christian Sandherr
Semperit skips 2025 dividend, positioned for FY26 growth
Yesterday, Semperit disclosed it will suspend a 2025 dividen [ … ]
Wed, 04.03.2026
Borussia Dortmund GmbH & Co KGaA
Company Name:
Borussia Dortmund GmbH & Co KGaA
ISIN:
DE0005493092
Reason for the research:
Update
Recommendation:
BUY
Target price:
EUR 5.1
Target price on sight of:
12 months
Last rating change:
Analyst:
Philipp Sennewald
Title hopes gone for 25/26 season; Chg.Topic: Within four days BVB got knocked out of the 2025/26 UCL [ … ]
Tue, 03.03.2026
EPH Group AG
Company Name:
EPH Group AG
ISIN:
AT0000A34DM3
Reason for the research:
Update
Recommendation:
BUY
Target price:
EUR 102
Target price on sight of:
12 months
Last rating change:
Analyst:
Philipp Sennewald
EPH enters Germany with two lakefront projects
EPH announced a principal agreement to acquire two premium hotel developments a [ … ]
Fri, 27.02.2026
Aiforia Technologies Oyj
Company Name:
Aiforia Technologies Oyj
ISIN:
FI4000507934
Reason for the research:
Update
Recommendation:
BUY
Target price:
EUR 3.8
Target price on sight of:
12 months
Last rating change:
Analyst:
Julius Neittamo
H2'25 preview; accelerating clinical revenue growth expectedAiforia will report H2’25 results on March 6. Our [ … ]
Fri, 27.02.2026
NFON AG
Company Name:
NFON AG
ISIN:
DE000A0N4N52
Reason for the research:
Update
Recommendation:
BUY
Target price:
EUR 8.7
Target price on sight of:
12 months
Last rating change:
Analyst:
Philipp Sennewald
Solid Q4 caps of difficult FY25; Chg.Topic: Yesterday, NFON released a solid set of preliminary FY25 figures, slightly overshooting [ … ]
Tue, 24.02.2026
Rosenbauer International AG
Company Name:
Rosenbauer International AG
ISIN:
AT0000922554
Reason for the research:
Update
Recommendation:
BUY
Target price:
EUR 61
Target price on sight of:
12 months
Last rating change:
Analyst:
Christian Sandherr
Commercial momentum to continue in 2026; Chg. PT
Rosenbauer recently provided several updates on its commercial [ … ]
Mon, 23.02.2026
ZEAL Network SE
Company Name:
ZEAL Network SE
ISIN:
DE000ZEAL241
Reason for the research:
Update
Recommendation:
BUY
Target price:
EUR 67
Target price on sight of:
12 months
Last rating change:
Analyst:
Simon Keller
The odds remain compelling
Following a multiple compression over the last years (2026e EV/EBITDA c. 37% below 5-year historic med [ … ]
